383 related articles for article (PubMed ID: 29038604)
1. Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis.
Ayaub EA; Dubey A; Imani J; Botelho F; Kolb MRJ; Richards CD; Ask K
Sci Rep; 2017 Oct; 7(1):13281. PubMed ID: 29038604
[TBL] [Abstract][Full Text] [Related]
2. RELMα is Induced in Airway Epithelial Cells by Oncostatin M Without Requirement of STAT6 or IL-6 in Mouse Lungs In Vivo.
Ho L; Yip A; Lao F; Botelho F; Richards CD
Cells; 2020 May; 9(6):. PubMed ID: 32471168
[TBL] [Abstract][Full Text] [Related]
3. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
4. Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo.
Dubey A; Izakelian L; Ayaub EA; Ho L; Stephenson K; Wong S; Kwofie K; Austin RC; Botelho F; Ask K; Richards CD
Immunol Cell Biol; 2018 Mar; 96(3):257-272. PubMed ID: 29363180
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent.
Fritz DK; Kerr C; Fattouh R; Llop-Guevara A; Khan WI; Jordana M; Richards CD
J Immunol; 2011 Jan; 186(2):1107-18. PubMed ID: 21160052
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
[TBL] [Abstract][Full Text] [Related]
7. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice.
Guo X; Li T; Xu Y; Xu X; Zhu Z; Zhang Y; Xu J; Xu K; Cheng H; Zhang X; Ke Y
J Biol Chem; 2017 Aug; 292(34):14003-14015. PubMed ID: 28687632
[TBL] [Abstract][Full Text] [Related]
9. Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.
Sennello JA; Misharin AV; Flozak AS; Berdnikovs S; Cheresh P; Varga J; Kamp DW; Budinger GR; Gottardi CJ; Lam AP
Am J Respir Cell Mol Biol; 2017 Feb; 56(2):191-201. PubMed ID: 27668462
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis.
Mozaffarian A; Brewer AW; Trueblood ES; Luzina IG; Todd NW; Atamas SP; Arnett HA
J Immunol; 2008 Nov; 181(10):7243-53. PubMed ID: 18981146
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor.
Lan YW; Theng SM; Huang TT; Choo KB; Chen CM; Kuo HP; Chong KY
Stem Cells Transl Med; 2017 Mar; 6(3):1006-1017. PubMed ID: 28297588
[TBL] [Abstract][Full Text] [Related]
12. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
Pechkovsky DV; Prasse A; Kollert F; Engel KM; Dentler J; Luttmann W; Friedrich K; Müller-Quernheim J; Zissel G
Clin Immunol; 2010 Oct; 137(1):89-101. PubMed ID: 20674506
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis.
Xie N; Cui H; Ge J; Banerjee S; Guo S; Dubey S; Abraham E; Liu RM; Liu G
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L834-L844. PubMed ID: 28798256
[TBL] [Abstract][Full Text] [Related]
14. MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis.
Gharib SA; Johnston LK; Huizar I; Birkland TP; Hanson J; Wang Y; Parks WC; Manicone AM
J Leukoc Biol; 2014 Jan; 95(1):9-18. PubMed ID: 23964118
[TBL] [Abstract][Full Text] [Related]
15. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C
Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis.
Tao B; Jin W; Xu J; Liang Z; Yao J; Zhang Y; Wang K; Cheng H; Zhang X; Ke Y
J Immunol; 2014 Sep; 193(6):2801-11. PubMed ID: 25127857
[TBL] [Abstract][Full Text] [Related]
17. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
[TBL] [Abstract][Full Text] [Related]
18. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts.
Takenouchi Y; Kitakaze K; Tsuboi K; Okamoto Y
Exp Cell Res; 2020 Jun; 391(2):112010. PubMed ID: 32305327
[TBL] [Abstract][Full Text] [Related]
20. HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.
Philip K; Mills TW; Davies J; Chen NY; Karmouty-Quintana H; Luo F; Molina JG; Amione-Guerra J; Sinha N; Guha A; Eltzschig HK; Blackburn MR
FASEB J; 2017 Nov; 31(11):4745-4758. PubMed ID: 28701304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
